Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter

Breast Cancer Research and Treatment

Volumn 61, Issue 2, 2000, Pages 111-119

  Bharaj, Bhupinder ^a,b   Scorilas, Andreas ^a,b   Diamandis, Eleftherios P ^a,b   Giai, Maurizia ^c   Levesque, Michael A ^a,b   Sutherland, Donald J A ^b   Hoffman, Barry R ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Androgen receptor; Breast cancer; Mutation; Polymorphism; Prognosis

Indexed keywords

ADENINE; ANDROGEN; GUANINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DEATH; FEMALE; GENOTYPE; HORMONE RESPONSIVE ELEMENT; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANDROGENS; BINDING SITES; BREAST NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; POINT MUTATION; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0033937206     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006459613498     Document Type: Article

References (33)

1. 1. Helzlsouer KJ, Couzi R: Hormones and breast cancer [Review]. Cancer 76(10): 2059-2063, 1995
2. 2. Levesquo MA, Yu H, D'Costa M, Diamandis EP: Prostate specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128, 1995
3. 3. Smith MR, Biggar S, Hussain M: Prostate specific antigen mRNA is expressed in non prostatic cells; implications for detection of micrometastases. Cancer Res 55: 2640-2644, 1995
4. 4. Lee C, Keefer M, Zhao ZW, Krose R, Berg L, Liu XX, Sensibar J: Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis. J Androl 10: 432-138, 1989
5. 5. Catalona WJ, Smith DS, Ratcliff TL, Dodds KM, Copelan DE, Yuan JJ, Petios JA, Andriole GL: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Eng J Med 324: 1156-1161, 1991
6. 6. Oesterling JE: Prostate specific antigen, a critical assessment of the most useful marker for adenocarcinoma of the prostate [Review]. J Urol 145: 907-923, 1991
7. 7. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M, Croce CM: Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171-178, 1996
8. 8. Diamandis EP, Yu H, Sutherland DJ: Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 32: 301-310, 1994
9. 9. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R, Sismondi P: Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995
10. 10. Yu H, Levesque MA, Clark GM, Diamandis EP: Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clin Cancer Res 4: 1489-1497, 1998
11. 11. Sauter ER, Daly M, Lenahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E: Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer. Cancer Epidemiol Biomarkers Prev 5: 967-970, 1996
12. 12. Young CYF, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ: Hormonal regulation of prostate specific antigen messenger RNA in human prostate adenocarcinoma cell line LNCaP. Cancer Res 51: 3748-3752, 1991
13. 13. Riegman PHJ, Vlietstra RJ, van der Korput JAGM, Brinkman AO, Trapman J: The promoter of the prostate specific antigen contains a functional androgen responsive element. Mol Endocrinol 5: 1921-1930, 1991
14. 14. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 75: 579-588, 1997
15. 15. Cleutjens KBJM, van Eekelen CCEM, van der Korput HAGM, Brinkmann AO, Trapman J: Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 271: 6379-6388, 1996
16. 16. Cleutjens KBJM, van der Korput HAGM, van Eekelen CCCM, van Riooji HCJ, Faber PW, Trapman J: An androgen responsive element in a far upstream enhancer region is essential for high androgen-regulated activity of the prostate specific antigen promoters. Mol Endocrinol 11: 148-1461, 1997
17. 17. Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso CL, DeKernion JB, Belldegrun AS: Prostate tissue specificity of prostate-specific antigen promoter isolated from a patient with prostate cancer. Human Gene Therapy 6: 1417-1426, 1995
18. 18. Lundwall A: Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161: 1151-1159, 1989
19. 19. Klobeck HG, Combriato G, Schultz P, Arbusow V, Fittler F: Genomic sequence of human prostate specific antigen (PSA). Nucleic Acids Res 17: 3981, 1987
20. 20. Majumdar S, Diamandis EP: The promoter of the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumors and breast carcinoma cell lines. Br J Cancer 79: 1594-1602, 1999
21. 21. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G: Illustrated guide to the TNM/pTNM classification of malignant tumors. TNM atlas, 3rd edn Springer-Verlag, Berlin, New York, 1989, p. 343
22. 22. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
23. 23. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR: Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 271: 7043-7051, 1996
24. 24. Bharaj BS, Angelopoulou K, Diamandis EP: Rapid sequencing of the p53 gene with a new automated sequencer. Clin Chem 44: 1397-1403, 1998
25. 25. Dressier LG, Seamer LC, Owens MA, Clark CM, McGuire WL: DNA flow cytometry and prognostic factors in 1131 frozen breast cancer specimens. Cancer 61: 420-427, 1988
26. 26. Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672, 1949
27. 27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with folin-phenol reagent. J Biol Chem 193: 265-275, 1951
28. 28. Alexiera-Figusch J, van Putten WLS, Blankestein MA, Blonk-Van Der wijst J, Klijn JGM: The prognostic value and relationships of patient characteristics, eslrogen and progestin receptors and site of relapse in primary breast cancer. Cancer 61: 758-768, 1988
29. 29. Reiher A, Kolb R, Reiner G, Jakesz R, Schemper M, Spona J: Prognostic significance of steroid hormone receptor and histopathologieal characterization of human breast cancer. J Cancer Res Clin Oncol 113: 285-290, 1987
30. 30. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP: Ultrasensitive detection of prostate specific antigen by a new time-resolved immunofluorometric assay and the Immulite immunochcmiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem 42: 675-684, 1996
31. 31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
32. 32. Cox DR: Regression models and life tables. R Stat Soc B 34: 187-202, 1972
33. 33. Tsuyuki D, Grass L, Diamandis EP: Frequent detection of mutations in the 5′flanking region of the prostate-specific antigen gene in female breast cancer. Eur J Cancer 33: 1853-1856, 1997